Appendix 2—table 28. Statin Non-user Cohort (All Regions) by BP Use, Patient Characteristics Pre/Post Match of BP Users/Non-users.
| All Statin Non-users by BP Use: Unmatched | All Statin Non-users by BP: Matched | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All | BP Non-users | BP Users | p-value | All | BP Non-users | BP Users | p-value | |||||||
| N | % | N | % | N | % | N | % | N | % | N | % | |||
| All Patients | 1,436,300 | 100.0% | 1,311,457 | 91.3% | 124,843 | 8.7% | 249,432 | 100.0% | 124,716 | 50.0% | 124,716 | 50.0% | ||
| Age | ||||||||||||||
| ≤20 | 1,387 | 0.1% | 1,383 | 0.1% | 4 | 0.0% | <0.001 | 6 | 0.0% | 2 | 0.0% | 4 | 0.0% | 0.99 |
| 21-40 | 44,371 | 3.1% | 44,170 | 3.4% | 201 | 0.2% | 413 | 0.2% | 212 | 0.2% | 201 | 0.2% | ||
| 41-50 | 135,748 | 9.5% | 134,305 | 10.2% | 1,443 | 1.2% | 2,880 | 1.2% | 1,437 | 1.2% | 1,443 | 1.2% | ||
| 51-60 | 354,449 | 24.7% | 336,779 | 25.7% | 17,670 | 14.2% | 35,335 | 14.2% | 17,665 | 14.2% | 17,670 | 14.2% | ||
| 61-70 | 428,326 | 29.8% | 381,936 | 29.1% | 46,390 | 37.2% | 92,791 | 37.2% | 46,401 | 37.2% | 46,390 | 37.2% | ||
| 71-80 | 303,279 | 21.1% | 264,157 | 20.1% | 39,122 | 31.3% | 78,077 | 31.3% | 39,037 | 31.3% | 39,040 | 31.3% | ||
| ≥81 | 168,740 | 11.7% | 148,727 | 11.3% | 20,013 | 16.0% | 39,930 | 16.0% | 19,962 | 16.0% | 19,968 | 16.0% | ||
| Gender | ||||||||||||||
| Female | 839,207 | 58.4% | 727,324 | 55.5% | 111,883 | 89.6% | <0.001 | 223,501 | 89.6% | 111,745 | 89.6% | 111,756 | 89.6% | 0.94 |
| Male | 597,093 | 41.6% | 584,133 | 44.5% | 12,960 | 10.4% | 25,931 | 10.4% | 12,971 | 10.4% | 12,960 | 10.4% | ||
| Region | ||||||||||||||
| Midwest | 271,319 | 18.9% | 249,383 | 19.0% | 21,936 | 17.6% | <0.001 | 43,870 | 17.6% | 21,935 | 17.6% | 21,935 | 17.6% | 1.00 |
| Northeast | 423,934 | 29.5% | 390,134 | 29.7% | 33,800 | 27.1% | 67,594 | 27.1% | 33,797 | 27.1% | 33,797 | 27.1% | ||
| South | 523,112 | 36.4% | 480,680 | 36.7% | 42,432 | 34.0% | 84,618 | 33.9% | 42,309 | 33.9% | 42,309 | 33.9% | ||
| West | 217,935 | 15.2% | 191,260 | 14.6% | 26,675 | 21.4% | 53,350 | 21.4% | 26,675 | 21.4% | 26,675 | 21.4% | ||
| Insurance | ||||||||||||||
| Commercial | 587,847 | 40.9% | 552,487 | 42.1% | 35,360 | 28.3% | <0.001 | 70,725 | 28.4% | 35,365 | 28.4% | 35,360 | 28.4% | 1.00 |
| Dual | 54,851 | 3.8% | 46,371 | 3.5% | 8,480 | 6.8% | 16,696 | 6.7% | 8,342 | 6.7% | 8,354 | 6.7% | ||
| Medicaid | 320,434 | 22.3% | 296,591 | 22.6% | 23,843 | 19.1% | 47,674 | 19.1% | 23,832 | 19.1% | 23,842 | 19.1% | ||
| Medicare | 473,168 | 32.9% | 416,008 | 31.7% | 57,160 | 45.8% | 114,337 | 45.8% | 57,177 | 45.8% | 57,160 | 45.8% | ||
| PCP Visit 2019 | ||||||||||||||
| No | 508,587 | 35.4% | 473,241 | 36.1% | 35,346 | 28.3% | <0.001 | 70,689 | 28.3% | 35,343 | 28.3% | 35,346 | 28.3% | 0.99 |
| Yes | 927,713 | 64.6% | 838,216 | 63.9% | 89,497 | 71.7% | 178,743 | 71.7% | 89,373 | 71.7% | 89,370 | 71.7% | ||
| Continuous Outcomes | ||||||||||||||
| mean | SD | mean | SD | mean | SD | p-value | mean | SD | mean | SD | mean | SD | p-value | |
| CCI | 1.12 | 1.79 | 1.13 | 1.79 | 1.02 | 1.86 | <0.001 | 1.02 | 1.85 | 1.02 | 1.84 | 1.02 | 1.86 | 0.49 |
BP: bisphosphonate; CCI: Charlson Comorbidity Index; PCP: primary care physician; SD: standard deviation.